Interaction of CCND1 genotype and smoking habit in taiwan lung cancer patients

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3601-3605

  Hsia, Te Chun ^a   Liu, Chin Jung ^a,b   Lin, Chih Hsueh ^a   Chang, Wen Shin ^a,b   Chu, Chia Chen ^a,b   Hang, Liang Wen ^a   Lee, Hong Zin ^b   Lo, Woei Chung ^a   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

CCND1; Cyclin D1; Lung cancer; Polymorphism; Smoking; Taiwanese

Indexed keywords

CYCLIN D1;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CELL CYCLE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; RISK FACTOR; SMOKING; TAIWAN;

CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TAIWAN;

EID: 80054732952     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Chen L, Elahi A, Pow-Sang J, Lazarus P and Park J: Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol 170: 2471-2474, 2003. (Pubitemid 37414037)
2. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleecker ER, Walsh PC, Meyers DA and Isaacs WB: Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 62: 2253-2257, 2002. (Pubitemid 34411700)
3. Shields PG and Harris CC: Cancer risk and low-penetrance susceptibility genes in gene environment interactions. J Clin Oncol 18: 2309-2315, 2000. (Pubitemid 30350224)
4. Shields PG: Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870-6876, 2002.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007. (Pubitemid 46148091)
6. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, URiche J, Samet JM, Srivastava S, Minna JD and Gazdar AF: Molecular damage in the bronchial epithelium of current and former smokers. J. Natl Cancer Inst 89: 1366-1373, 1997. (Pubitemid 27418028)
7. Gazdar AF: Cell biology and molecular biology of small cell and non-small cell lung cancer. Curr Opin Oncol 2: 321-327, 1990.
8. Testa JR: Chromosome alterations in human lung cancer. In: Lung Cancer: Principles and Practice. Lippincott-Raven, Philadelphia, pp. 55-71, 1996.
9. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
10. Sherr CJ: D Type cyclins. Trends Biochem Sci 20: 187-190, 1995.
11. Donnellan R and Chetty R: Cyclin D1 and human neoplasia. Mol Pathol 51: 1-7, 1998. (Pubitemid 28157349)
12. Kandel R, Zhu XL, Li SQ and Rohan T: Cyclin D1 protein overexpression and gene amplification in benign breast tissue and breast cancer risk. Eur J Cancer Prev 10: 43-51, 2001. (Pubitemid 32200201)
13. Hemmer S, Wasenius VM, Haglund C, Zhu Y, Knuutila S, Franssila K and Joensuu H: Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol 158: 1355-1362, 2001. (Pubitemid 32281299)
14. Coqueret O: Linking cyclins to transcriptional control. Gene 299: 35-55, 2002.
15. Fu M, Wang C, Li Z, Sakamaki T and Pestell RG: Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447, 2004. (Pubitemid 39564581)
16. Jayasurya R, Sathyan KM, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, Nair MK and Kannan S: Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol 18: 1056-1066, 2005. (Pubitemid 41224496)
17. Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridan BF, Jensen MJ, Morgan GJ, Hughes CJ and Sutherland RL: Cyclin D1 and p16 INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 5: 2810-2819, 1999. (Pubitemid 29493956)
18. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
19. Qiuling S, Yuxin Z, Suhua Z, Cheng X, Shuguang L and Fengsheng H: Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis 24: 1499-1503, 2003. (Pubitemid 37160840)
20. Buch S, Zhu B, Davis AG, Odom D, Siegfried JM, Grandis JR and Romkes M: Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aerodigestive tract. Mol Carcinog 42: 222-228, 2005.
21. Gautschi O, Hugh B, Ziegler A, Bigosch C, Bowers NL, Ratschiller D, Jermann M, Stahel RA, Heighway J and Betticher DC: Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung Cancer 51: 303-311, 2006. (Pubitemid 43265813)
22. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WD, Cerny T and Thatcher N: Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br J Cancer 73: 294-300, 1996. (Pubitemid 26047506)
23. Chang CH, Chiu CF, Wang HC, Wu HC, Tsai RY, Tsai CW, Wang RF, Wang CH, Tsou YA and Bau DT: Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 5121-5124, 2009.
24. Chang CH, Wang RF, Tsai RY, Wu HC, Wang CH, Tsai CW, Chang CL, Tsou YA, Liu CS and Bau DT: Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 3903-3907, 2009.
25. Liu CJ, Hsia TC, Wang RF, Tsai CW, Chu CC, Hang LW, Wang CH, Lee HZ, Tsai RY and Bau DT: Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients. Anticancer Res 30: 1195-1199, 2010.
26. Liu CS, Tsai CW, Hsia TC, Wang RF, Liu CJ, Hang LW, Chiang SY, Wang CH, Tsai RY, Lin CC and Bau DT: Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics 6: 325-329, 2009.
27. Wang HC, Chiu CF, Tsai RY, Kuo YS, Chen HS, Wang RF, Tsai CW, Chang CH, Lin CC and Bau DT: Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. Anticancer Res 29: 3897-3901, 2009.
28. Wang HC, Liu CS, Chiu CF, Chiang SY, Wang CH, Wang RF, Lin CC, Tsai RY and Bau DT: Significant association of DNA repair gene KU80 genotypes with breast cancer susceptibility in Taiwan. Anticancer Res 29: 5251-5254, 2009.
29. Akkiz H, Bayram S, Bekar A, Akgollu E and Ozdil B: Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case control study. Cancer Epidemiol 34: 298-302.
30. Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W and Szyfter K: Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol 263: 43-48, 2006. (Pubitemid 43004710)
31. Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E and Unal H: CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res 30: 3093-3098, 2010.
32. Jiang J, Wang J, Suzuki S, Gajalakshmi V, Kuriki K, Zhao Y, Nakamura S, Akasaka S, Ishikawa H and Tokudome S: Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 132: 193-199, 2006. (Pubitemid 43015780)
33. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, Schulte-Witte H, Plassmann D, Rahner N, Aretz S, Friedrichs N, Buettner R, Sauerbruch T and Lammert F: Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23: 147-154, 2008. (Pubitemid 350302510)
34. Yuan L, Gu X, Shao J, Wang M, Wang M, Zhu Q and Zhang Z: Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol 29: 611-617, 2010.
35. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol 44: 689-697, 2008. (Pubitemid 351842821)
36. Yaylim-Eraltan I, Arikan S, Yildiz Y, Cacina C, Ergen HA, Tuna G, Gormus U, Zeybek U and Isbir T: The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res 30: 2875-2880, 2010.
37. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 42: 607-613, 2006. (Pubitemid 43947667)
38. Gomes CC, Drummond SN, Guimaraes AL, Andrade CI, Mesquita RA and Gomez RS: P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med 37: 151-156, 2008. (Pubitemid 351178410)
39. Gangwar R and Mittal RD: Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population. DNA Cell Biol 29: 349-356, 2010.
40. Jain M, Kumar S, Upadhyay R, Lal P, Tiwari A, Ghoshal UC and Mittal B: Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer Biol Ther 6: 1553-1558, 2007. (Pubitemid 351590326)
41. Satinder K, Chander SR, Pushpinder K, Indu G and Veena J: Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case-control study in north Indian population. Mol Cell Biochem 315: 151-157, 2008.